CN1500772A - 4-乙酸基-2-乙氧基苯甲酸乙酯的合成方法 - Google Patents
4-乙酸基-2-乙氧基苯甲酸乙酯的合成方法 Download PDFInfo
- Publication number
- CN1500772A CN1500772A CNA021451915A CN02145191A CN1500772A CN 1500772 A CN1500772 A CN 1500772A CN A021451915 A CNA021451915 A CN A021451915A CN 02145191 A CN02145191 A CN 02145191A CN 1500772 A CN1500772 A CN 1500772A
- Authority
- CN
- China
- Prior art keywords
- acetoacetic ester
- ethoxy benzonitrile
- benzonitrile acetoacetic
- synthetic method
- acetoxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000010189 synthetic method Methods 0.000 title claims description 9
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- -1 4-acetoxyl-2-ethoxy benzonitrile Chemical compound 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 5
- 229960003328 benzoyl peroxide Drugs 0.000 claims description 5
- AJOOJWNBCFXLFS-UHFFFAOYSA-N CCOc1cc(I)ccc1C#N Chemical compound CCOc1cc(I)ccc1C#N AJOOJWNBCFXLFS-UHFFFAOYSA-N 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- 238000010931 ester hydrolysis Methods 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 235000015320 potassium carbonate Nutrition 0.000 claims description 4
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 3
- 229940045803 cuprous chloride Drugs 0.000 claims description 3
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 230000032050 esterification Effects 0.000 claims description 2
- 238000005886 esterification reaction Methods 0.000 claims description 2
- 230000002140 halogenating effect Effects 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- DXTLCLWOCYLDHL-UHFFFAOYSA-N 2-ethoxybenzonitrile Chemical compound CCOC1=CC=CC=C1C#N DXTLCLWOCYLDHL-UHFFFAOYSA-N 0.000 claims 3
- 230000000058 esterolytic effect Effects 0.000 claims 2
- PJRLUGQMEZZDIY-UHFFFAOYSA-N 4-ethoxybenzonitrile Chemical compound CCOC1=CC=C(C#N)C=C1 PJRLUGQMEZZDIY-UHFFFAOYSA-N 0.000 claims 1
- AJBAIEIZLKPREH-UHFFFAOYSA-N CCOC1(C#N)CC=CC=C1 Chemical compound CCOC1(C#N)CC=CC=C1 AJBAIEIZLKPREH-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 abstract 1
- 229960004909 aminosalicylic acid Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 description 4
- 229960002354 repaglinide Drugs 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000003810 ethyl acetate extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- JDVUCGQRDDFTJL-UHFFFAOYSA-N 3-carbamoyl-2-methylbenzoic acid Chemical class CC1=C(C(N)=O)C=CC=C1C(O)=O JDVUCGQRDDFTJL-UHFFFAOYSA-N 0.000 description 1
- HCEQQASHRRPQFE-UHFFFAOYSA-N 5-chloro-n-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide;3-(diaminomethylidene)-1,1-dimethylguanidine;hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N.COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 HCEQQASHRRPQFE-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- ZLWLTDZLUVBSRJ-UHFFFAOYSA-K chembl2360149 Chemical compound [Na+].[Na+].[Na+].O=C1C(N=NC=2C=CC(=CC=2)S([O-])(=O)=O)=C(C(=O)[O-])NN1C1=CC=C(S([O-])(=O)=O)C=C1 ZLWLTDZLUVBSRJ-UHFFFAOYSA-K 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- FATAVLOOLIRUNA-UHFFFAOYSA-N formylmethyl Chemical group [CH2]C=O FATAVLOOLIRUNA-UHFFFAOYSA-N 0.000 description 1
- 229940112611 glucovance Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02145191 CN1215040C (zh) | 2002-11-12 | 2002-11-12 | 4-羧甲基-2-乙氧基苯甲酸乙酯的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02145191 CN1215040C (zh) | 2002-11-12 | 2002-11-12 | 4-羧甲基-2-乙氧基苯甲酸乙酯的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1500772A true CN1500772A (zh) | 2004-06-02 |
CN1215040C CN1215040C (zh) | 2005-08-17 |
Family
ID=34232298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02145191 Expired - Lifetime CN1215040C (zh) | 2002-11-12 | 2002-11-12 | 4-羧甲基-2-乙氧基苯甲酸乙酯的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1215040C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008046995A1 (de) * | 2008-09-12 | 2010-03-18 | Stada Arzneimittel Ag | 2-Ethoxy-benzoesäurederivat |
WO2015135096A1 (zh) * | 2014-03-13 | 2015-09-17 | 河北科技大学 | 3-乙氧基-4-乙氧羰基苯乙酸的合成方法 |
CN107868005A (zh) * | 2016-09-28 | 2018-04-03 | 齐鲁工业大学 | 一种羧酸化合物的晶体结构及荧光性能 |
CN112079712A (zh) * | 2020-09-18 | 2020-12-15 | 江苏美迪克化学品有限公司 | 一种对乙烯基水杨酸的制备方法 |
CN115420826A (zh) * | 2022-08-30 | 2022-12-02 | 北京悦康科创医药科技股份有限公司 | 一种枸橼酸爱地那非原料药中起始物料邻乙氧基苯甲酸中杂质的分离检测方法 |
-
2002
- 2002-11-12 CN CN 02145191 patent/CN1215040C/zh not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008046995A1 (de) * | 2008-09-12 | 2010-03-18 | Stada Arzneimittel Ag | 2-Ethoxy-benzoesäurederivat |
DE102008046995B4 (de) * | 2008-09-12 | 2010-08-26 | Stada Arzneimittel Ag | 2-Ethoxy-benzoesäurederivat |
WO2015135096A1 (zh) * | 2014-03-13 | 2015-09-17 | 河北科技大学 | 3-乙氧基-4-乙氧羰基苯乙酸的合成方法 |
CN107868005A (zh) * | 2016-09-28 | 2018-04-03 | 齐鲁工业大学 | 一种羧酸化合物的晶体结构及荧光性能 |
CN112079712A (zh) * | 2020-09-18 | 2020-12-15 | 江苏美迪克化学品有限公司 | 一种对乙烯基水杨酸的制备方法 |
CN115420826A (zh) * | 2022-08-30 | 2022-12-02 | 北京悦康科创医药科技股份有限公司 | 一种枸橼酸爱地那非原料药中起始物料邻乙氧基苯甲酸中杂质的分离检测方法 |
CN115420826B (zh) * | 2022-08-30 | 2023-05-30 | 北京悦康科创医药科技股份有限公司 | 一种枸橼酸爱地那非原料药中起始物料邻乙氧基苯甲酸中杂质的分离检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1215040C (zh) | 2005-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60125747T2 (de) | Verfahren zur herstellung von 2-halobenzoesäuren | |
CN103814023B (zh) | 4,4-二氟-3,4-二氢异喹啉衍生物的制造方法 | |
CN101704763B (zh) | 阿戈美拉汀i型晶体的制备方法 | |
CN1215040C (zh) | 4-羧甲基-2-乙氧基苯甲酸乙酯的合成方法 | |
CN103159659A (zh) | 一种毒蕈碱受体拮抗剂格隆溴铵的制备方法 | |
EP0089011B1 (de) | Verfahren zur Herstellung von 3-Oxonitrilen | |
EP2880013A1 (de) | Verfahren zum herstellen von substituierten biphenylen durch c-h-aktivierung | |
WO2007115685A1 (de) | Verfahren zum herstellen von biphenylaminen über vinylaniline | |
WO2009127116A1 (zh) | 13-卤代-3,15-二氧代赤霉酸酯及其制备方法 | |
CN101121664B (zh) | 一种肉桂酸乙酯衍生物的制备方法 | |
KR101049475B1 (ko) | 아자-바이사이클로[2.2.1]헵텐 유도체, 이의 제조방법 및 이를 이용한 오셀타미비르의 중간체의 제조방법 | |
Hunter et al. | Dimyristo-and Eruco-stearo-cephalin | |
CN1234690C (zh) | 白藜芦醇烟酸酯及其合成方法 | |
Liu et al. | Radical coupling of arylthiodifluoroacetic acids and ethynylbenziodoxolone (EBX) reagents to access arylthiodifluoromethylated alkynes | |
CN109232316B (zh) | 一类α-三级腈结构β-二羰基化合物的合成方法 | |
JP2005306791A (ja) | アビエタンキノン化合物の製造方法 | |
CN108137485A (zh) | 苯甲酸酰胺化合物的制备方法 | |
CN106336378A (zh) | 一种喹啉‑2‑甲酸酯系列物的制备方法 | |
US7368593B1 (en) | Method of selective esterification | |
CN101367785A (zh) | 2-羟基丙二羰类化合物的合成在黄酮醇类合成中的应用 | |
CN110981781A (zh) | 一种吲哚美辛及其类似物的合成方法 | |
CN1724537A (zh) | 一种合成甲磺酸帕珠沙星中间体的方法 | |
CN114195753B (zh) | 一种钌催化一锅法制备3,4-二苯基异香豆素衍生物的制备方法 | |
ITMI961683A1 (it) | Procedimento per la preparazione di acidi 2-aril-propionici e 2-aril-acetici a partire da aril-olefine | |
EP0649831B1 (de) | Verfahren zur Herstellung von 3-(p-Fluorphenyl)-2-methylpropionsäure und 3-(p-Fluorphenyl)-2-methylpropionsäurederivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: SHANGHAI SUNVE PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 200331 No. 50, Yongdeng Road, Shanghai, China Patentee after: SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL Co.,Ltd. Address before: 200331 No. 50, Yongdeng Road, Shanghai Patentee before: Shanghai Sunve Pharmaceutical Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20050817 |
|
CX01 | Expiry of patent term | ||
DD01 | Delivery of document by public notice |
Addressee: Pan Haifei Document name: Notice of termination upon expiration of patent right |
|
DD01 | Delivery of document by public notice |